NasdaqGS - Nasdaq Real Time Price USD

Masimo Corporation (MASI)

134.74 -1.18 (-0.87%)
As of 2:10 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Joseph E. Kiani Founder, CEO & Chairman 3.31M -- 1965
Mr. Micah Young Executive VP & CFO 1.13M -- 1979
Mr. Bilal Muhsin Chief Operating Officer 1.2M -- 1981
Mr. Thomas Samuel McClenahan Executive VP, General Counsel & Corporate Secretary 957.51k -- 1973
Mr. Tao Leopold Levy Executive Vice President of Business Development 798.52k -- 1974
Mr. Paul Hataishi Senior VP & Chief Accounting Officer -- -- 1975
Mr. Yongsam Lee Executive VP & Chief Information Officer 1.1M 1.2M 1965
Dr. Steven J. Barker Chairman of Scientific Advisory Board & Chief Science Officer 139.56k -- 1945
Mr. Eli Kammerman Vice President of Business Development & Investor Relations -- -- --
Mr. Jon Coleman President of Worldwide Sales, Professional Services & Medical Affairs 584.59k 5.57M 1964

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000 https://www.masimo.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
3,800

Description

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Corporate Governance

Masimo Corporation’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 3; Board: 8; Shareholder Rights: 3; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 07, 2024 - May 13, 2024
Masimo Corporation Earnings Call

Related Tickers

GMED Globus Medical, Inc.
50.15
-1.18%
 
NARI Inari Medical, Inc.
38.59
-0.13%
 
ITGR Integer Holdings Corporation
116.65
-1.00%
 
PODD Insulet Corporation
164.05
-0.42%
 
DXCM DexCom, Inc.
130.30
-2.98%
 
SWAV Shockwave Medical, Inc.
328.10
+0.18%
 
ALGN Align Technology, Inc.
298.93
-0.80%
 
EW Edwards Lifesciences Corporation
85.77
-0.79%
 
PRCT PROCEPT BioRobotics Corporation
49.23
-3.62%
 
INSP Inspire Medical Systems, Inc.
230.54
-4.40%